Background The virus neutralization assay is a principal method to assess the efficacy of
antibodies in blocking viral entry. Due to biosafety handling requirements of viruses …

Viral infections are causing serious problems in human population worldwide. The recent
outbreak of coronavirus disease 2019 caused by SARS‐CoV‐2 is a perfect example how …

The production and use of pseudotyped viral particles are widely established for many
viruses, and applications in the fields of serology and vaccine development are manifold …

Serological assays detecting neutralising antibodies are important for determining the
immune responses following infection or vaccination and are also often considered a …

Equine populations worldwide are at increasing risk of infection by viruses transmitted by
biting arthropods, including mosquitoes, biting midges (Culicoides), sandflies and ticks …

The globalization of the world's economies, accompanied by increasing international travel,
changing climates, altered human behaviour and demographics is leading to the …

Ebola virus (EBOV) is an enveloped, single-stranded RNA virus that can cause Ebola virus
disease (EVD). It is thought that EVD survivors are protected against subsequent infection …

Pseudotype viruses (PVs) are chimeric, replication-deficient virions that mimic wild-type
virus entry mechanisms and can be safely employed in neutralisation assays, bypassing the …

Emerging diseases are frequently caused by novel or previously unrecognised zoonotic
viral pathogens, which tend to originate in and emerge from wildlife. When human or animal …

Given the possibility of yellow fever virus reintroduction in epidemiologically receptive
geographic areas, the risk of vaccine supply disruption is a serious issue. New strategies to …